Pathological complete response to neoadjuvant lorlatinib in a patient with unresectable ALK-Positive locally advanced non-small cell lung cancer: A case report

por Chen, Ruiqi, Zhao, Lilan, Zhang, Juan, Guo, Lingwen, Chen, Zhizhong, Pan, Xiaojie, Chen, Wenshu
Publicado 2023

USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination

por Zhu, Lihuan, Chen, Zhizhong, Guo, Tianxing, Chen, Wenshu, Zhao, Lilan, Guo, Lingwen, Pan, Xiaojie
Publicado 2022